Arthritis Research UK is the resource for anyone looking for the latest news in the fight against arthritis. We’re providing answers today and tomorrow toward a future free from arthritis.
A maximum of 200 results have been returned
A Turkish study has identified a beneficial effect of the anti-TNF therapy infliximab in addressing cardiac abnormalities in patients with rheumatoid arthritis.
Find out more
Tocilizumab has been approved in Europe for use in patients with severe, active and progressive rheumatoid arthritis who previously have not been treated with methotrexate.
A University of Bristol study has achieved a breakthrough in treating autoimmune diseases by developing a method of preventing cells from attacking healthy body tissue.
A protein biomarker panel has been developed with the potential to predict response to biological therapy in psoriatic arthritis patients.
A new Arthritis Research UK-funded study from the University of Liverpool has uncovered insights into how cells alter their behavior at the onset of osteoarthritis.
A newly identified biomarker could be used to detect early rheumatoid arthritis better than conventional methods alone, according to a new study.
A tailored approach to reducing doses of anti-TNF drugs among ankylosing spondylitis patients can deliver cost-effectiveness benefits without impacting the efficacy of treatment.
A new study has shed light on possible molecular biomarkers that can be used to predict treatment response rates in rheumatoid arthritis patients.
Regular walking has been linked with a decreased risk of functional limitation in knee osteoarthritis patients.
Finger length patterns have been identified as a potential biomarker for osteoarthritis and chronic joint pain.